Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 23
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Danaher Corp
DHR
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$229.75
-4.11
-1.76%
Ult. Agg.: Oct 22, 6:27 PM
$229.75
-4.11
-1.76%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Privacy Manager
PRO
Perché si muove?:
Danaher shares are trading higher after the company reported better-than-ex...
Utili:
I risultati di Q3 2026 sono stati pubblicati in data mer ott 21st, prima dell'apertura del mercato
Conference call:
La conference call più recente è iniziata alle 8:00 AM, 1 giorno fa
Clicca per vedere il webcast
Danaher Financials
Danaher (DHR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation
Danaher shares fell despite upbeat Q3 results. TD Cowen raised its target, citing tariffs and a cautious 2027 outlook.
Priya Nigam
Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
Danaher beat Q3 earnings and revenue estimates, raised FY2026 profit guidance, and analysts lifted price targets despite shares falling 1.8%.
Avi Kapoor
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
Vandana Singh
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International, Thermo Fisher
Benzinga Insights
PRO
Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY
Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
Benzinga Newsdesk
PRO
Danaher Q3 Adj. EPS $2.11 Beats $1.92 Estimate, Sales $6.554B Miss $6.559B Estimate
Benzinga Newsdesk
